Safe Orthopaedics Valuation
| ALSAF Stock | EUR 0.05 0 5.44% |
Safe Orthopaedics seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Safe Orthopaedics from inspecting the company fundamentals such as Operating Margin of (1.35) %, return on equity of -639.4, and Shares Outstanding of 79.68 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Safe Orthopaedics' price fluctuation is out of control at this time. Calculation of the real value of Safe Orthopaedics is based on 3 months time horizon. Increasing Safe Orthopaedics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Safe Orthopaedics' intrinsic value may or may not be the same as its current market price of 0.05, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0539 | Real 0.0517 | Hype 0.05 |
The intrinsic value of Safe Orthopaedics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Safe Orthopaedics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Safe Orthopaedics SA helps investors to forecast how Safe stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Safe Orthopaedics more accurately as focusing exclusively on Safe Orthopaedics' fundamentals will not take into account other important factors: Safe Orthopaedics Total Value Analysis
Safe Orthopaedics SA is presently projected to have takeover price of 10.42 M with market capitalization of 147.41 M, debt of 5.28 M, and cash on hands of 913 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Safe Orthopaedics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.42 M | 147.41 M | 5.28 M | 913 K |
Safe Orthopaedics Investor Information
The company has price-to-book (P/B) ratio of 0.4. Some equities with similar Price to Book (P/B) outperform the market in the long run. Safe Orthopaedics recorded a loss per share of 11536.24. The entity had not issued any dividends in recent years. The firm had 3000:1 split on the 16th of September 2024. Based on the key indicators related to Safe Orthopaedics' liquidity, profitability, solvency, and operating efficiency, Safe Orthopaedics SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Safe Orthopaedics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Safe Orthopaedics has an asset utilization ratio of 30.65 percent. This connotes that the Company is making €0.31 for each dollar of assets. An increasing asset utilization means that Safe Orthopaedics SA is more efficient with each dollar of assets it utilizes for everyday operations.Safe Orthopaedics Profitability Analysis
The company reported the revenue of 4.56 M. Net Loss for the year was (6.71 M) with profit before overhead, payroll, taxes, and interest of 2.57 M.About Safe Orthopaedics Valuation
The stock valuation mechanism determines Safe Orthopaedics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Safe Orthopaedics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Safe Orthopaedics. We calculate exposure to Safe Orthopaedics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Safe Orthopaedics's related companies.Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company was founded in 2010 and is headquartered in ragny-sur-Oise, France. SAFE ORTHOPAEDICS operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 134 people.
8 Steps to conduct Safe Orthopaedics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Safe Orthopaedics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Safe Orthopaedics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Safe Orthopaedics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Safe Orthopaedics' revenue streams: Identify Safe Orthopaedics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Safe Orthopaedics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Safe Orthopaedics' growth potential: Evaluate Safe Orthopaedics' management, business model, and growth potential.
- Determine Safe Orthopaedics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Safe Orthopaedics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Safe Stock Analysis
When running Safe Orthopaedics' price analysis, check to measure Safe Orthopaedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safe Orthopaedics is operating at the current time. Most of Safe Orthopaedics' value examination focuses on studying past and present price action to predict the probability of Safe Orthopaedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safe Orthopaedics' price. Additionally, you may evaluate how the addition of Safe Orthopaedics to your portfolios can decrease your overall portfolio volatility.